Alok Bhutada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alok Bhutada has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Adnan Sadiq
Department of Cardiology, Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219, USA
1 shared publicationAnju Gupta
Division of Neonatology, Maimonides Infants Children Hospital of Brooklyn, 1048 Tenth Avenue, G-103, Brooklyn, NY 11203, USA
1 shared publicationC. Perez
Department of Medicine, College of Physicians and Surgeons, ColumbiaUniversity, New York, New York 10032
1 shared publicationD. Y. Chon
Department of Medicine, College of Physicians and Surgeons, ColumbiaUniversity, New York, New York 10032
1 shared publicationDavid A. Gutman
Department of Anesthesiology, Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219, USA
1 shared publication- Deepa Rastogi
Department of Pediatrics, Division of Respiratory and Sleep Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
1 shared publication
Latest Publications
- Open Access
- 25 April 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology Reports
- Vol. 06 (02) , e243-e245
Topical Iodine–Induced Thyrotoxicosis in a Newborn with a Giant Omphalocele
Introduction Neonatal thyrotoxicosis is a life-threatening condition with potentially irreversible neurologic sequelae. Most cases are seen in neonates born to mothers with Graves' disease. Topical iodine–induced hypothyroidism has been reported in neonates, but iodine–induced neonatal hyperthyroidism has not been described; albeit a familiar entity in adults. Case Description Herein we present a unique case of a neonate, born with a giant omphalocele, who was treated with topical povidone-iodine dressings to promote escharification, in preparation for delayed surgical closure. By third day of life (DOL), the baby presented with a suppressed thyroid stimulating hormone of 0.59 µIU/mL, elevated free thyroxine of 5.63 ng/dL, and frank cardiovascular manifestations of thyrotoxicosis. After replacement of the topical iodine dressings with iodine-free silver sulfadiazine, the thyroid status gradually improved with complete resolution of hyperthyroidism by 17th DOL. Conclusion This case emphasizes that significant topical iodine exposure can result in both hypothyroidism and hyperthyroidism, and therefore, vigilance in monitoring thyroid function is imperative.
- 25 April 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology Reports
- Vol. 06 (02) , e243-e245
Open AccessTopical Iodine–Induced Thyrotoxicosis in a Newborn with a Giant Omphalocele
Introduction Neonatal thyrotoxicosis is a life-threatening condition with potentially irreversible neurologic sequelae. Most cases are seen in neonates born to mothers with Graves' disease. Topical iodine–induced hypothyroidism has been reported in neonates, but iodine–induced neonatal hyperthyroidism has not been described; albeit a familiar entity in adults. Case Description Herein we present a unique case of a neonate, born with a giant omphalocele, who was treated with topical povidone-iodine dressings to promote escharification, in preparation for delayed surgical closure. By third day of life (DOL), the baby presented with a suppressed thyroid stimulating hormone of 0.59 µIU/mL, elevated free thyroxine of 5.63 ng/dL, and frank cardiovascular manifestations of thyrotoxicosis. After replacement of the topical iodine dressings with iodine-free silver sulfadiazine, the thyroid status gradually improved with complete resolution of hyperthyroidism by 17th DOL. Conclusion This case emphasizes that significant topical iodine exposure can result in both hypothyroidism and hyperthyroidism, and therefore, vigilance in monitoring thyroid function is imperative.
- Open Access
- 21 May 2015
- Published by Wiley in Case Reports in Anesthesiology
- Vol. 2015, 1-4
A Multidisciplinary Approach to Anesthetic Management of a Parturient with Severe Aortic Stenosis
In order to optimize anesthetic management and avoid adverse maternal and fetal outcomes, a clear understanding of the changes in cardiovascular physiology that occur during pregnancy is paramount. The effects of normal gestation on the cardiovascular system are particularly significant in a parturient with cardiac valvular pathology. We present a case of a 27-year-old G2P0 at 37 weeks with a past medical history of diabetes, macrosomia, congenital bicuspid aortic valve with severe stenosis (valve area 0.7 cm2) who was scheduled for elective C-section. A multidisciplinary discussion involving cardiologists, cardiac surgeons, obstetric surgeons, neonatal intensivists, perfusion staff, anesthesiologists, and nursing staff was held to formulate a plan for the perioperative management of this parturient. Also, contingency plans were formulated and discussed with the care providers, in the event of acute decompensation of the mother and baby and possible need for emergency aortic valvuloplasty and/or aortic valve replacement.
- 21 May 2015
- Published by Wiley in Case Reports in Anesthesiology
- Vol. 2015, 1-4
Open AccessA Multidisciplinary Approach to Anesthetic Management of a Parturient with Severe Aortic Stenosis
In order to optimize anesthetic management and avoid adverse maternal and fetal outcomes, a clear understanding of the changes in cardiovascular physiology that occur during pregnancy is paramount. The effects of normal gestation on the cardiovascular system are particularly significant in a parturient with cardiac valvular pathology. We present a case of a 27-year-old G2P0 at 37 weeks with a past medical history of diabetes, macrosomia, congenital bicuspid aortic valve with severe stenosis (valve area 0.7 cm2) who was scheduled for elective C-section. A multidisciplinary discussion involving cardiologists, cardiac surgeons, obstetric surgeons, neonatal intensivists, perfusion staff, anesthesiologists, and nursing staff was held to formulate a plan for the perioperative management of this parturient. Also, contingency plans were formulated and discussed with the care providers, in the event of acute decompensation of the mother and baby and possible need for emergency aortic valvuloplasty and/or aortic valve replacement.
- Open Access
- 8 December 2011
- Published by Wiley in International Journal of Pediatrics
- Vol. 2012, 1-7
Factors Affecting the Weaning from Nasal CPAP in Preterm Neonates
Objective. Identification of the weight and postmenstrual age (PMA) at successful weaning of NCPAP in preterm neonates and the factors influencing the successful wean.Study Design. Retrospective review of 454 neonates ≤32 weeks of gestational age (GA) who were placed on NCPAP and successfully weaned to room air was performed.Results. Neonates had a mean birth weight (BW) of grams with a mean GA of weeks. Neonates were weaned off NCPAP at mean weight of grams and mean PMA of weeks. Univariate analysis showed that chorioamnionitis, intubation, surfactant use, PDA, sepsis/NEC, anemia, apnea, GER and IVH were significantly associated with the time to NCPAP wean. On multivariate analysis, among neonates that were intubated, BW was the only significant factor () that was inversely related to time to successful NCPAP wean. Amongst non-intubated neonates, along with BW (), chorioamnionitis (), anemia (), and GER () played a significant role in weaning from NCPAP.Conclusion. Neonates were weaned off NCPAP at mean weight of grams and mean PMA of weeks. BW significantly affects weaning among intubated and non-intubated neonates, though in neonates who were never intubated chorioamnionitis, anemia and GER also significantly affected the duration on NCPAP.
- 8 December 2011
- Published by Wiley in International Journal of Pediatrics
- Vol. 2012, 1-7
Open AccessFactors Affecting the Weaning from Nasal CPAP in Preterm Neonates
Objective. Identification of the weight and postmenstrual age (PMA) at successful weaning of NCPAP in preterm neonates and the factors influencing the successful wean.Study Design. Retrospective review of 454 neonates ≤32 weeks of gestational age (GA) who were placed on NCPAP and successfully weaned to room air was performed.Results. Neonates had a mean birth weight (BW) of grams with a mean GA of weeks. Neonates were weaned off NCPAP at mean weight of grams and mean PMA of weeks. Univariate analysis showed that chorioamnionitis, intubation, surfactant use, PDA, sepsis/NEC, anemia, apnea, GER and IVH were significantly associated with the time to NCPAP wean. On multivariate analysis, among neonates that were intubated, BW was the only significant factor () that was inversely related to time to successful NCPAP wean. Amongst non-intubated neonates, along with BW (), chorioamnionitis (), anemia (), and GER () played a significant role in weaning from NCPAP.Conclusion. Neonates were weaned off NCPAP at mean weight of grams and mean PMA of weeks. BW significantly affects weaning among intubated and non-intubated neonates, though in neonates who were never intubated chorioamnionitis, anemia and GER also significantly affected the duration on NCPAP.
- 1 June 1990
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 258 (6) , C1044-C1050
Induction of Na(+)-K(+)-ATPase and its subunit mRNAs by serum in a rat liver cell line
Addition of serum to confluent Clone 9 cells increased the protein, RNA, and DNA content per plate of cells; the increments became manifest within 3-6 h and were sustained for the 48-h duration of study. After the addition of serum, Na(+)-K(+)-ATPase activity was stimulated 1.25- and 1.45-fold at 6 and 12 h, respectively. In cells preincubated in the absence of serum for 24 h, addition of serum increased the abundances of Na(+)-K(+)-ATPase subunit mRNAs, mRNA alpha 1 and mRNA beta, coordinately by approximately 2- and 2.7-fold at 3 h, an effect that preceded the stimulation of Na(+)-K(+)-ATPase activity. The serum-induced increments in subunit mRNA abundances were further enhanced by the combined presence of serum and cycloheximide; mRNA alpha 1 and mRNA beta abundances were also augmented by cycloheximide alone (approximately 2.5- and 9.2-fold at 6 h, respectively). In cells incubated in the absence of serum, the half-lives of mRNA alpha 1 and mRNA beta, estimated from decrements in their abundances after the addition of actinomycin D, were 12 and 10 h, respectively. These data demonstrate that serum enhances Na(+)-K(+)-ATPase subunit mRNA abundance and enzyme activity in Clone 9 cells. Comparison of the estimated half-lives of Na(+)-K(+)-ATPase subunit mRNAs with the observed increments in their abundances at 3 h suggests that the serum-induced increases in mRNA alpha 1 and mRNA beta abundances are in large part due to enhanced synthesis of these mRNAs.
- 1 June 1990
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 258 (6) , C1044-C1050
Induction of Na(+)-K(+)-ATPase and its subunit mRNAs by serum in a rat liver cell line
Addition of serum to confluent Clone 9 cells increased the protein, RNA, and DNA content per plate of cells; the increments became manifest within 3-6 h and were sustained for the 48-h duration of study. After the addition of serum, Na(+)-K(+)-ATPase activity was stimulated 1.25- and 1.45-fold at 6 and 12 h, respectively. In cells preincubated in the absence of serum for 24 h, addition of serum increased the abundances of Na(+)-K(+)-ATPase subunit mRNAs, mRNA alpha 1 and mRNA beta, coordinately by approximately 2- and 2.7-fold at 3 h, an effect that preceded the stimulation of Na(+)-K(+)-ATPase activity. The serum-induced increments in subunit mRNA abundances were further enhanced by the combined presence of serum and cycloheximide; mRNA alpha 1 and mRNA beta abundances were also augmented by cycloheximide alone (approximately 2.5- and 9.2-fold at 6 h, respectively). In cells incubated in the absence of serum, the half-lives of mRNA alpha 1 and mRNA beta, estimated from decrements in their abundances after the addition of actinomycin D, were 12 and 10 h, respectively. These data demonstrate that serum enhances Na(+)-K(+)-ATPase subunit mRNA abundance and enzyme activity in Clone 9 cells. Comparison of the estimated half-lives of Na(+)-K(+)-ATPase subunit mRNAs with the observed increments in their abundances at 3 h suggests that the serum-induced increases in mRNA alpha 1 and mRNA beta abundances are in large part due to enhanced synthesis of these mRNAs.